Papers
2
Total Citations
37
H-Index
2
About
Dr. Assilah Bouzit is a leading urologic surgeon and researcher whose work focuses on optimizing surgical outcomes in robotic partial nephrectomy for renal tumors. Her primary research areas include nephron-sparing surgery, renal ischemia techniques, and the integration of advanced imaging for complex tumor resection. Dr. Bouzit’s most impactful contribution is the EMERALD randomized controlled trial (2021, 32 citations), which demonstrated that superselective ischemia during robotic partial nephrectomy does not provide superior long-term renal function compared to standard renal artery clamping, challenging a widely adopted practice and prompting surgeons to reconsider the risk-benefit balance of this technique. She is also the lead investigator of the ACCURATE trial (2025), a multicenter randomized study evaluating three-dimensional image-guided robot-assisted partial nephrectomy for complex renal tumors, with the protocol already cited 5 times. This work positions her at the forefront of precision surgery, aiming to improve oncologic and functional outcomes through technological innovation. Dr. Bouzit’s research has direct implications for clinical guidelines, helping to refine surgical strategies that balance tumor control with renal preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2